- Home
- LDP vs AXGN Comparison
LDP vs AXGN Comparison
Compare LDP & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDP
- AXGN
- Stock Information
- Founded
- LDP 2012
- AXGN N/A
- Country
- LDP United States
- AXGN United States
- Employees
- LDP N/A
- AXGN N/A
- Industry
- LDP Finance Companies
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LDP Finance
- AXGN Health Care
- Exchange
- LDP Nasdaq
- AXGN Nasdaq
- Market Cap
- LDP 607.2M
- AXGN 584.7M
- IPO Year
- LDP N/A
- AXGN N/A
- Fundamental
- Price
- LDP $20.90
- AXGN $12.64
- Analyst Decision
- LDP
- AXGN Strong Buy
- Analyst Count
- LDP 0
- AXGN 4
- Target Price
- LDP N/A
- AXGN $15.00
- AVG Volume (30 Days)
- LDP 102.5K
- AXGN 444.1K
- Earning Date
- LDP 01-01-0001
- AXGN 11-07-2024
- Dividend Yield
- LDP 7.91%
- AXGN N/A
- EPS Growth
- LDP N/A
- AXGN N/A
- EPS
- LDP N/A
- AXGN N/A
- Revenue
- LDP N/A
- AXGN $180,855,000.00
- Revenue This Year
- LDP N/A
- AXGN $18.91
- Revenue Next Year
- LDP N/A
- AXGN $12.93
- P/E Ratio
- LDP N/A
- AXGN N/A
- Revenue Growth
- LDP N/A
- AXGN 18.79
- 52 Week Low
- LDP $16.16
- AXGN $5.55
- 52 Week High
- LDP $20.30
- AXGN $15.90
- Technical
- Relative Strength Index (RSI)
- LDP 41.58
- AXGN 42.96
- Support Level
- LDP $20.77
- AXGN $12.18
- Resistance Level
- LDP $21.70
- AXGN $14.17
- Average True Range (ATR)
- LDP 0.28
- AXGN 1.00
- MACD
- LDP -0.02
- AXGN -0.19
- Stochastic Oscillator
- LDP 13.44
- AXGN 25.74
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.